• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

TNFRSF1B 和 TNF 变体与重症 COVID-19 患者可溶性肿瘤坏死因子受体水平的差异相关。

TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19.

机构信息

HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.

Translational Research Laboratory on Aging and Pulmonary Fibrosis, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico.

出版信息

J Infect Dis. 2022 Sep 13;226(5):778-787. doi: 10.1093/infdis/jiac101.

DOI:10.1093/infdis/jiac101
PMID:35294530
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8992340/
Abstract

BACKGROUND

The impact of genetic variants in the expression of tumor necrosis factor-α (TNF-α) and its receptors in coronavirus disease 2019 (COVID-19) severity has not been previously explored. We evaluated the association of TNF (rs1800629 and rs361525), TNFRSF1A (rs767455 and rs1800693), and TNFRSF1B (rs1061622 and rs3397) variants with COVID-19 severity, assessed as invasive mechanical ventilation (IMV) requirement, and the plasma levels of soluble TNF-α, TNFR1, and TNFR2 in patients with severe COVID-19.

METHODS

The genetic study included 1353 patients. Taqman assays were used to assess the genetic variants. ELISA was used to determine soluble TNF-α, TNFR1, and TNFR2 in plasma samples from 334 patients.

RESULTS

Patients carrying TT (TNFRSF1B rs3397) exhibited lower PaO2/FiO2 levels than those with CT + CC genotypes. Differences in plasma levels of TNFR1 and TNFR2 were observed according to the genotype of TNFRSF1B rs1061622, TNF rs1800629, and rs361525. According to the studied genetic variants, there were no differences in the soluble TNF-α levels. Higher soluble TNFR1 and TNFR2 levels were detected in patients with COVID-19 requiring IMV.

CONCLUSIONS

Genetic variants in TNF and TNFRSFB1 influence the plasma levels of soluble TNFR1 and TNFR2, implicated in COVID-19 severity.

摘要

背景

肿瘤坏死因子-α（TNF-α）及其受体在 2019 年冠状病毒病（COVID-19）严重程度中的表达的遗传变异的影响尚未被探索。我们评估了 TNF（rs1800629 和 rs361525）、TNFRSF1A（rs767455 和 rs1800693）和 TNFRSF1B（rs1061622 和 rs3397）变体与 COVID-19 严重程度的关联，严重 COVID-19 患者的评估指标为有创机械通气（IMV）需求以及可溶性 TNF-α、TNFR1 和 TNFR2 的血浆水平。

方法

该遗传研究包括 1353 例患者。Taqman 测定法用于评估遗传变异。ELISA 用于测定 334 例患者血浆样本中的可溶性 TNF-α、TNFR1 和 TNFR2。

结果

与 CT + CC 基因型相比，携带 TT（TNFRSF1B rs3397）的患者的 PaO2/FiO2 水平较低。根据 TNFRSF1B rs1061622、TNF rs1800629 和 rs361525 的基因型观察到 TNFR1 和 TNFR2 的血浆水平存在差异。根据研究的遗传变异，可溶性 TNF-α水平没有差异。需要 IMV 的 COVID-19 患者的可溶性 TNFR1 和 TNFR2 水平较高。

结论

TNF 和 TNFRSFB1 中的遗传变异影响可溶性 TNFR1 和 TNFR2 的血浆水平，这与 COVID-19 的严重程度有关。

相似文献

1
TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19.TNFRSF1B 和 TNF 变体与重症 COVID-19 患者可溶性肿瘤坏死因子受体水平的差异相关。
J Infect Dis. 2022 Sep 13;226(5):778-787. doi: 10.1093/infdis/jiac101.
2
Association of TNF-α, TNFRSF1A and TNFRSF1B gene polymorphisms with the risk of sporadic breast cancer in northeast Chinese Han women.肿瘤坏死因子-α、肿瘤坏死因子受体超家族成员1A和肿瘤坏死因子受体超家族成员1B基因多态性与中国东北汉族女性散发性乳腺癌风险的相关性
PLoS One. 2014 Jul 10;9(7):e101138. doi: 10.1371/journal.pone.0101138. eCollection 2014.
3
Role of TNFRSF1A and TNFRSF1B polymorphisms in susceptibility, severity, and therapeutic efficacy of etanercept in human leukocyte antigen-B27-positive Chinese Han patients with ankylosing spondylitis.TNFRSF1A和TNFRSF1B基因多态性在肿瘤坏死因子受体超家族成员1A和1B基因多态性在人类白细胞抗原-B27阳性中国汉族强直性脊柱炎患者中对依那西普易感性、严重程度及治疗疗效的作用
Medicine (Baltimore). 2018 Aug;97(31):e11677. doi: 10.1097/MD.0000000000011677.
4
The tumor necrosis factor receptor superfamily member 1B polymorphisms predict response to anti-TNF therapy in patients with autoimmune disease: A meta-analysis.肿瘤坏死因子受体超家族成员1B基因多态性预测自身免疫性疾病患者对抗肿瘤坏死因子治疗的反应：一项荟萃分析。
Int Immunopharmacol. 2015 Sep;28(1):146-53. doi: 10.1016/j.intimp.2015.05.049. Epub 2015 Jun 9.
5
Knockouts of and Genes in K562 Cell Line Lead to Diverse Long-Lasting Responses to TNF-α.和基因敲除导致 K562 细胞系对 TNF-α 产生多样化的持久反应。
Int J Mol Sci. 2023 Dec 6;24(24):17169. doi: 10.3390/ijms242417169.
6
TNF receptors 1 and 2 exert distinct region-specific effects on striatal and hippocampal grey matter volumes (VBM) in healthy adults.肿瘤坏死因子受体1和2对健康成年人的纹状体和海马灰质体积（体素形态学测量）具有不同的区域特异性影响。
Genes Brain Behav. 2017 Mar;16(3):352-360. doi: 10.1111/gbb.12318. Epub 2016 Oct 4.
7
Behavior of tumor necrosis factor-α and tumor necrosis factor receptor 1/tumor necrosis factor receptor 2 system in mononuclear cells recovered from peritoneal fluid of women with endometriosis at different stages.在不同阶段的子宫内膜异位症女性腹腔液中回收的单核细胞中肿瘤坏死因子-α 和肿瘤坏死因子受体 1/肿瘤坏死因子受体 2 系统的行为。
Reprod Sci. 2015 Feb;22(2):165-72. doi: 10.1177/1933719114536472. Epub 2014 May 20.
8
The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis.肿瘤坏死因子（TNF）-α和TNF受体多态性在强直性脊柱炎易感性中的作用。
Clin Exp Rheumatol. 2009 Jul-Aug;27(4):645-8.
9
Genetic polymorphisms in tumour necrosis factor receptors () illustrate differential treatment response to TNFα inhibitors in patients with Crohn's disease.肿瘤坏死因子受体的基因多态性表明克罗恩病患者对肿瘤坏死因子α抑制剂的治疗反应存在差异。
BMJ Open Gastroenterol. 2019 Feb 1;6(1):e000246. doi: 10.1136/bmjgast-2018-000246. eCollection 2019.
10
Interaction between tumor cell TNFR2 and monocyte membrane-bound TNF-α triggers tumorigenic inflammation in neuroblastoma.肿瘤细胞 TNFR2 与单核细胞膜结合型 TNF-α 相互作用引发神经母细胞瘤致瘤性炎症。
J Immunother Cancer. 2023 Mar;11(3). doi: 10.1136/jitc-2022-005478.

引用本文的文献

1
High nasopharyngeal and serum IL-6 levels and the - 573G > C polymorphism (rs1800796) are linked with the risk of severe COVID-19 in a Mexican population: a case‒control study.高鼻咽和血清白细胞介素-6水平以及-573G>C多态性（rs1800796）与墨西哥人群中重症COVID-19的风险相关：一项病例对照研究。
BMC Infect Dis. 2025 Mar 5;25(1):315. doi: 10.1186/s12879-025-10695-y.
2
TNF/IFN-γ Co-Signaling Induces Differential Cellular Activation in COVID-19 Patients: Implications for Patient Outcomes.肿瘤坏死因子/干扰素-γ共信号传导在新冠病毒肺炎患者中诱导不同的细胞活化：对患者预后的影响
Int J Mol Sci. 2025 Jan 28;26(3):1139. doi: 10.3390/ijms26031139.
3

本文引用的文献

1
Severe COVID-19 Patients Show an Increase in Soluble TNFR1 and ADAM17, with a Relationship to Mortality.严重 COVID-19 患者可溶性 TNFR1 和 ADAM17 增加，与死亡率相关。
Int J Mol Sci. 2021 Aug 5;22(16):8423. doi: 10.3390/ijms22168423.
2
Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.COVID-19 相关急性呼吸窘迫综合征和肺外多器官功能障碍患者炎症细胞因子风暴中的特定细胞因子。
Virol J. 2021 Jun 4;18(1):117. doi: 10.1186/s12985-021-01588-y.
3
Increased Serum Levels of Soluble TNF-α Receptor Is Associated With ICU Mortality in COVID-19 Patients.
Exploring TNFR1: from discovery to targeted therapy development.
探索肿瘤坏死因子受体1：从发现到靶向治疗的发展
J Transl Med. 2025 Jan 15;23(1):71. doi: 10.1186/s12967-025-06122-0.
4
The BCG vaccine and SARS-CoV-2: Could there be a beneficial relationship?卡介苗与新型冠状病毒：它们之间会存在有益关系吗？
Heliyon. 2024 Sep 19;10(18):e38085. doi: 10.1016/j.heliyon.2024.e38085. eCollection 2024 Sep 30.
5
COVID-19 Inflammatory Syndrome: Lessons from TNFRI and CRP about the Risk of Death in Severe Disease.新冠病毒 19 型炎症综合征：从肿瘤坏死因子受体 1 和 C 反应蛋白看重症疾病死亡风险的经验教训
Biomedicines. 2024 Sep 20;12(9):2138. doi: 10.3390/biomedicines12092138.
6
Implication of IL-12A, IL-12B, IL-6, and TNF single-nucleotide polymorphisms in severity and susceptibility to COVID-19.白细胞介素-12A、白细胞介素-12B、白细胞介素-6 和肿瘤坏死因子单核苷酸多态性与 COVID-19 严重程度和易感性的关系。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241279893. doi: 10.1177/03946320241279893.
7
14-bp variant is associated with exercise-induced oxygen desaturation in the post-COVID-19 condition.14个碱基对的变异与新冠康复后的运动诱发氧饱和度下降有关。
ERJ Open Res. 2024 Jul 15;10(4). doi: 10.1183/23120541.01038-2023. eCollection 2024 Jul.
8
Impact of (rs3397, rs1061624 and rs1061622) and (rs1800796, rs1800797 and rs1554606) Gene Polymorphisms on Inflammatory Response in Patients with End-Stage Kidney Disease Undergoing Dialysis.（rs3397、rs1061624和rs1061622）及（rs1800796、rs1800797和rs1554606）基因多态性对终末期肾病透析患者炎症反应的影响
Biomedicines. 2024 May 31;12(6):1228. doi: 10.3390/biomedicines12061228.
9
Genetic variants in as risk factors for mortality in patients unrelated but not associated with families with severe COVID-19.与严重 COVID-19 家庭无亲缘关系的患者中，[相关基因名称]的基因变异作为死亡风险因素，但无关联。 （你提供的原文“in as”表述有误，推测应该是某个基因名称，这里按照纠正后的理解翻译，若有误请根据正确原文调整）
Heliyon. 2024 Apr 9;10(8):e29493. doi: 10.1016/j.heliyon.2024.e29493. eCollection 2024 Apr 30.
10
The effect of ACE2 receptor, IFN-γ, and TNF-α polymorphisms on the severity and prognosis of the disease in SARS-CoV-2 infection.ACE2 受体、IFN-γ 和 TNF-α 多态性对严重急性呼吸综合征冠状病毒 2 感染疾病严重程度和预后的影响。
J Investig Med. 2023 Jun;71(5):526-535. doi: 10.1177/10815589231158379. Epub 2023 Mar 6.
新冠病毒肺炎患者血清可溶性肿瘤坏死因子-α受体水平升高与重症监护病房死亡率相关。
Front Immunol. 2021 Apr 22;12:592727. doi: 10.3389/fimmu.2021.592727. eCollection 2021.
4
COVID-19: Immunology, Immunopathogenesis and Potential Therapies.新型冠状病毒肺炎：免疫学、免疫发病机制及潜在疗法
Int Rev Immunol. 2022;41(2):171-206. doi: 10.1080/08830185.2021.1883600. Epub 2021 Feb 27.
5
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects.肿瘤坏死因子受体：多效性信号复合物及其差异效应
Front Immunol. 2020 Nov 25;11:585880. doi: 10.3389/fimmu.2020.585880. eCollection 2020.
6
Association between five types of Tumor Necrosis Factor-α gene polymorphism and hepatocellular carcinoma risk: a meta-analysis.肿瘤坏死因子-α基因多态性与肝细胞癌风险的关联：荟萃分析。
BMC Cancer. 2020 Nov 23;20(1):1134. doi: 10.1186/s12885-020-07606-6.
7
Association of TNF-α G-308 a Promoter Polymorphism with the Course and Outcome of COVID-19 Patients.TNF-α G-308A 启动子多态性与 COVID-19 患者病程和转归的关联。
Immunol Invest. 2022 Apr;51(3):546-557. doi: 10.1080/08820139.2020.1851709. Epub 2020 Nov 23.
8
Circulating Levels of Interleukin-6 and Interleukin-10, But Not Tumor Necrosis Factor-Alpha, as Potential Biomarkers of Severity and Mortality for COVID-19: Systematic Review with Meta-analysis.循环白细胞介素-6 和白细胞介素-10 水平，而不是肿瘤坏死因子-α，作为 COVID-19 严重程度和死亡率的潜在生物标志物：系统评价与荟萃分析。
J Clin Immunol. 2021 Jan;41(1):11-22. doi: 10.1007/s10875-020-00899-z. Epub 2020 Oct 31.
9
A meta-analysis of tumor necrosis factor (TNF) gene polymorphism and susceptibility to influenza A (H1N1).肿瘤坏死因子（TNF）基因多态性与甲型流感（H1N1）易感性的荟萃分析。
Comput Biol Chem. 2020 Dec;89:107385. doi: 10.1016/j.compbiolchem.2020.107385. Epub 2020 Sep 28.
10
Longitudinal changes of inflammatory parameters and their correlation with disease severity and outcomes in patients with COVID-19 from Wuhan, China.中国武汉 COVID-19 患者炎症参数的纵向变化及其与疾病严重程度和结局的相关性。
Crit Care. 2020 Aug 27;24(1):525. doi: 10.1186/s13054-020-03255-0.